坎伯蘭藥業 CPIX 深 滬
已收盤 02-06 16:00:00 美东时间
3.91
+0.320
+8.91%
華盛通- 最 高3.98
- 今 開3.54
- 成交量 10.28万股
- 最 低 3.54
- 昨 收 3.59
- 總市值 5848.04万
- 52周最高 7.25
- 市盈率 靜 --
- 換手率 0.69%
- 52周最低 1.85
- 委 比 72.57%
- 總股本 1495.66万
- 歷史最高 8.02
- 量 比 0.28
- 振 幅 12.26%
- 歷史最低 1.04
- 每 手 1
- 風險率 1.05%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cumberland Pharmaceuticals Wins Fast Track for Ifetroban
Cumberland Pharmaceuticals ( ($CPIX) ) has issued an announcement. On February ...
02-05 06:51
FDA Grants Fast Track Designation For Cumberland Pharma's Oral Therapy Targeting Fatal Form Of Heart Disease In Duchenne Muscular Dystrophy Patients
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a specialty pharmaceutical company focused on developing new products for rare diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted
02-04 22:06
Cumberland's Caldolor Injection Receives Permanent J-Code With Reimbursement
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), today announced an important update regarding its Caldolor® (ibuprofen) Injection. The product's permanent J-code, J1741, is now officially associated with a
2025-12-08 22:11
Cumberland Pharmaceuticals Reports Revenue Growth and Strategic Expansions
Cumberland Pharmaceuticals Inc. ( ($CPIX) ) has released its Q3 earnings. Here ...
2025-11-05 12:59
Cumberland Q3 Adj. EPS $(0.06) Down From $(0.02) YoY, Sales $8.292M Down From $9.086M YoY
Cumberland (NASDAQ:CPIX) reported quarterly losses of $(0.06) per share. This is a 200 percent decrease over losses of $(0.02) per share from the same period last year. The company reported $8.292 million in sales this
2025-11-05 06:01
CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH
NASHVILLE, Tenn., Nov. 4, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved ...
2025-11-05 06:00
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE
NASHVILLE, Tenn., Oct. 28, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its third quarter 202...
2025-10-29 04:05
Cumberland Pharmaceuticals Partners with RedHill for Talicia
Cumberland Pharmaceuticals ( ($CPIX) ) just unveiled an announcement. On Octobe...
2025-10-21 21:47
RedHill's Talicia® Secures $4 Million Strategic Investment and U.S. Co-Commercialization Partnership Deal
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) invests $4 million in exchange for a 30% ownership stake and joint control in RedHill's Talicia business U.S. co-commercialization partnership ...
2025-10-20 21:00
Cumberland Pharma Adds Potent Antibiotic, Vibativ, To National Group Purchasing Agreement With Premier
Premier Membership includes 4,350 U.S. HospitalsNASHVILLE, Tenn., Oct. 13, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a specialty pharmaceutical company, has added their potent antibiotic,
2025-10-13 21:12
